Atherosclerosis
Volume 195, Issue 2 , Pages 262-268 , December 2007

Functional analysis of the genetic variability in the F7 gene promoter

  • Maria Sabater-Lleal

      Affiliations

    • Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona 08025, Spain
    • ,
  • Miguel Chillón

      Affiliations

    • Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain
    • Centre de Biologia Animal i Teràpia Gènica (CBATEG), Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona 08193, Spain
    • ,
  • Tom E. Howard

      Affiliations

    • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    • ,
  • Estel Gil

      Affiliations

    • Centre de Biologia Animal i Teràpia Gènica (CBATEG), Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona 08193, Spain
    • ,
  • Laura Almasy

      Affiliations

    • Southwest Foundation for Biomedical Research (SFBR), San Antonio, TX 78245, USA
    • ,
  • John Blangero

      Affiliations

    • Southwest Foundation for Biomedical Research (SFBR), San Antonio, TX 78245, USA
    • ,
  • Jordi Fontcuberta

      Affiliations

    • Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona 08025, Spain
    • ,
  • José Manuel Soria

      Affiliations

    • Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona 08025, Spain
    • Corresponding Author InformationCorresponding author at: Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, C/Sant Antoni M. Claret 167, 08025 Barcelona, Spain. Tel.: +34 93 2919193; fax: +34 93 2919192.

Received 26 July 2006 ,Revised 24 November 2006 ,Accepted 19 December 2006.

References 

  1. Bauer KA, Kass BL, ten Cate H, et al. Factor IX is activated in vivo by the tissue factor mechanism. Blood. 1990;76(4):731–736
  2. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA. 1977;74(12):5260–5264
  3. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2(8506):533–537
  4. de Maat MP, Green F, de Knijff P, et al. Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol. 1997;17(10):1918–1923
  5. Iacoviello L, Donati MB. Blood coagulation factor VII activity and the risk of myocardial infarction: the novel identification of a genetic protection that can be mimicked by an old drug. G Ital Cardiol. 1998;28(6):718–721
  6. Green F, Kelleher C, Wilkes H, et al. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb. 1991;11(3):540–546
  7. Bernardi F, Marchetti G, Pinotti M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol. 1996;16(1):72–76
  8. Souto JC, Almasy L, Borrell M, et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation. 2000;101(13):1546–1551
  9. Soria JM, Almasy L, Souto JC, et al. The F7 gene and clotting factor VII levels: dissection of a human quantitative trait locus. Hum Biol. 2005;77(5):561–575
  10. Blangero J, Goring H, Kent J, et al. Quantitative trait nucleotide analysis using Bayesian model selection. Hum biology. 2005;77(5):541–559
  11. Lindman AS, Pedersen JI, Hjerkinn EM, et al. The influence of the −401G/T and −402G/A polymorphisms of the coagulation FVII promoter on plasma levels of FVII. Thromb Res. 2005;116(4):313–320
  12. Carew JA, Basso F, Miller GJ, et al. A functional haplotype in the 5′ flanking region of the factor VII gene is associated with an increased risk of coronary heart disease. J Thromb Haemost. 2003;1(10):2179–2185
  13. Bozzini C, Girelli D, Bernardi F, et al. Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis. Thromb Haemost. 2004;92(3):541–549
  14. Eriksson-Berg M, Deguchi H, Hawe E, et al. Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middle-aged women with and without manifest coronary heart disease. Thromb Haemost. 2005;93(2):351–358
  15. Dell’Acqua G, Iacoviello L, D’Orazio A, et al. A polymorphic cluster in the 5′ region of the human coagulation factor VII gene: detection, frequency, and linkage disequilibrium. Thromb Res. 1997;88(5):445–448
  16. van ’t Hooft FM, Silveira A, Tornvall P, et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood. 1999;93(10):3432–3441
  17. Gambaro G, Anglani F, D’Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet. 2000;355(9200):308–311
  18. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273(5281):1516–1517
  19. Ioannidis JP. Genetic associations: false or true?. Trends Mol Med. 2003;9(4):135–138
  20. Fisher CL, Pei GK. Modification of a PCR-based site-directed mutagenesis method. Biotechniques. 1997;23(4):570-1, 574
  21. Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther. 1998;5(5):712–717
  22. Taupin JL, Merville P, McBride T, et al. Functional quantification of cyclosporine A and FK506 in human whole blood by flow cytometry, using the green fluorescent protein as an interleukin-2 reporter gene. J Immunol Meth. 2001;256(1–2):77–87
  23. Niswender KD, Blackman SM, Rohde L, et al. Quantitative imaging of green fluorescent protein in cultured cells: comparison of microscopic techniques, use in fusion proteins and detection limits. J Microsc. 1995;180(Pt 2):109–116
  24. Souto JC, Almasy L, Borrell M, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet. 2000;67(6):1452–1459
  25. Pollak ES, Hung HL, Godwin W, et al. Functional characterization of the human factor VII 5′-flanking region. J Biol Chem. 1996;271(3):1738–1747
  26. Sabater-Lleal M, Martinez-Marchan E, Martinez-Sanchez E, et al. Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications. Haematologica. 2003;88(8):906–913
  27. Sabater-Lleal M, Soria JM, Bertranpetit J, et al. Human F7 sequence is split into three deep clades that are related to FVII plasma levels. Hum Genet. 2006;118(6):741–751

PII: S0021-9150(07)00028-7

doi: 10.1016/j.atherosclerosis.2006.12.031

Atherosclerosis
Volume 195, Issue 2 , Pages 262-268 , December 2007

Article Tools

* Image Usage & Resolution